Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease.

× No keyword cloud information.

27 in total

1. High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer.

Authors: O Mir; S Ropert; J Alexandre; F Lemare; F Goldwasser
Journal: Ann Oncol Date: 2008-10-09 Impact factor: 32.976

2. Systemic high-dose intravenous methotrexate for central nervous system metastases.

Authors: Andrew B Lassman; Lauren E Abrey; Gaurav D Shah; Gaurav G Shah; Katherine S Panageas; Martin Begemann; Mark G Malkin; Jeffrey J Raizer
Journal: J Neurooncol Date: 2006-07 Impact factor: 4.130

Review 3. [Guideline 'Leptomeningeal metastases of solid tumours'].

Authors: W Boogerd; W F J du Bois; J L J M Teepen; C J G M Rosenbrand
Journal: Ned Tijdschr Geneeskd Date: 2007-01-13

Review 4. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.

Authors: Yok-Lam Kwong; Dominic Y M Yeung; Joyce C W Chan
Journal: Ann Hematol Date: 2008-12-03 Impact factor: 3.673

5. Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study.

Authors: Jaishri O Blakeley; Jeffrey Olson; Stuart A Grossman; Xiaoying He; Jon Weingart; Jeffrey G Supko
Journal: J Neurooncol Date: 2008-09-12 Impact factor: 4.130

6. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.

Authors: Fusako Waki; Masashi Ando; Atsuo Takashima; Kan Yonemori; Hiroshi Nokihara; Mototaka Miyake; Ukihide Tateishi; Koji Tsuta; Yasuhiro Shimada; Yasuhiro Fujiwara; Tomohide Tamura
Journal: J Neurooncol Date: 2008-11-29 Impact factor: 4.130

7. Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.

Authors: Nancy U Lin; Lisa A Carey; Minetta C Liu; Jerry Younger; Steven E Come; Matthew Ewend; Gordon J Harris; Elizabeth Bullitt; Annick D Van den Abbeele; John W Henson; Xiaochun Li; Rebecca Gelman; Harold J Burstein; Elizabeth Kasparian; David G Kirsch; Ann Crawford; Fred Hochberg; Eric P Winer
Journal: J Clin Oncol Date: 2008-04-20 Impact factor: 44.544

8. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.

Authors: Kadri Altundag; Melissa L Bondy; Nadeem Q Mirza; Shu-Wan Kau; Kristine Broglio; Gabriel N Hortobagyi; Edgardo Rivera
Journal: Cancer Date: 2007-12-15 Impact factor: 6.860

2. An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity.

Authors: Harrison Naung; Kenneth J Cohen
Journal: J Neurooncol Date: 2021-03-10 Impact factor: 4.130

Review 3. Durable Response of Leptomeningeal Metastasis of Breast Cancer to Salvage Intrathecal Etoposide After Methotrexate: A Case Report and Literature Review.

Authors: Min Jae Park
Journal: Am J Case Rep Date: 2015-08-10

3 in total

Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease.